ReCerise Therapeutics Inc. is a bioventure company established in 2020, focusing on the development of innovative therapies for cancer and immune metabolic diseases. The company aims to create First-in-class and Best-in-class treatments, leveraging its proprietary technologies to address unmet medical needs in these challenging areas. Their commitment to advancing therapeutic solutions is underscored by a robust pipeline that reflects their dedication to scientific excellence and innovation.

The company’s research and development efforts are centered around cutting-edge technologies that enhance the efficacy and safety of therapeutic candidates. By integrating advanced scientific methodologies, ReCerise Therapeutics is positioned to make significant contributions to the fields of oncology and immunology. Their strategic approach not only emphasizes the development of novel treatments but also aims to improve patient outcomes through targeted and effective therapeutic interventions.

South Korea

ReCerise Therapeutics is a biotechnology company that focuses on developing first-in-class therapeutics and diagnostics targeting liver-specific proteins.

ReCerise Therapeutics

Company Details